GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Athanase Innovation AB (OSTO:ATIN) » Definitions » EBIT

Athanase Innovation AB (OSTO:ATIN) EBIT : kr192.77 Mil (TTM As of Dec. 2020)


View and export this data going back to 2017. Start your Free Trial

What is Athanase Innovation AB EBIT?

Athanase Innovation AB's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2020 was kr173.82 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2020 was kr192.77 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Athanase Innovation AB's annualized ROC % for the quarter that ended in Dec. 2020 was -0.68%. Athanase Innovation AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2020 was 106.21%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Athanase Innovation AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2020 was 49.03%.

Athanase Innovation AB EBIT Historical Data

The historical data trend for Athanase Innovation AB's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Athanase Innovation AB EBIT Chart

Athanase Innovation AB Annual Data
Trend Jun17 Jun18 Jun19
EBIT
- 20.82 22.09

Athanase Innovation AB Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20
EBIT Get a 7-Day Free Trial 10.79 11.30 3.03 18.95 173.82

Competitive Comparison of Athanase Innovation AB's EBIT

For the Asset Management subindustry, Athanase Innovation AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Athanase Innovation AB's EV-to-EBIT Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Athanase Innovation AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Athanase Innovation AB's EV-to-EBIT falls into.


Athanase Innovation AB EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2020 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr192.77 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Athanase Innovation AB  (OSTO:ATIN) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Athanase Innovation AB's annualized ROC % for the quarter that ended in Dec. 2020 is calculated as:

ROC % (Q: Dec. 2020 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2020 ) + Invested Capital (Q: Dec. 2020 ))/ count )
=-2.282 * ( 1 - 0.17% )/( (667.313 + 6.349)/ 2 )
=-2.2781206/336.831
=-0.68 %

where

Invested Capital(Q: Jun. 2020 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=676.91 - 3.079 - ( 14.909 - max(0, 15.773 - 22.291+14.909))
=667.313

Invested Capital(Q: Dec. 2020 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=403.681 - 0.584 - ( 403.624 - max(0, 6.933 - 403.681+403.624))
=6.349

Note: The Operating Income data used here is two times the semi-annual (Dec. 2020) data.

2. Joel Greenblatt's definition of Return on Capital:

Athanase Innovation AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2020 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2020 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2020  Q: Dec. 2020
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=347.642/( ( (654.619 + max(-7.206, 0)) + (0 + max(-6.9330000000001, 0)) )/ 2 )
=347.642/( ( 654.619 + 0 )/ 2 )
=347.642/327.3095
=106.21 %

where Working Capital is:

Working Capital(Q: Jun. 2020 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4.467 + 0 + 0) - (3.079 + 0 + 8.594)
=-7.206

Working Capital(Q: Dec. 2020 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + -5.6843418860808E-14) - (0.584 + 0 + 6.349)
=-6.9330000000001

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2020) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Athanase Innovation AB's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2020 )
=192.772/393.187
=49.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Athanase Innovation AB EBIT Related Terms

Thank you for viewing the detailed overview of Athanase Innovation AB's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Athanase Innovation AB (OSTO:ATIN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Athanase Innovation AB (OSTO:ATIN) » Definitions » EBIT
Comparable Companies
EVG SMM NHS XTER:L1OA LSE:IGV LSE:ATS ASX:GVF HKSE:01051 MSD LSE:NTN
Traded in Other Exchanges
N/A
Address
Nybrogatan 3, Stockholm, SWE, 114 34
Website
https://www.athanaseinnovation.com
Athanase Innovation AB is an alternative investment firm with exposure to both private and public equity. It invests in innovative companies that benefit from trends such as robotics, digitalization, and automation. The principal revenue stream is initially management fees charged on the external fund capital and investment income of the underlying assets.

Athanase Innovation AB (OSTO:ATIN) Headlines

No Headlines